Valproate Sodium
- Product NDC
- 70860-784
- 11-digit product format
- 708600784
- Labeler code
- 70860
- Product ID
- 70860-784_37440743-cd78-454a-8d6e-305376ec8bd4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- valproate sodium
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA076295
- Marketing category
- ANDA
- Marketing start
- 2022-11-01
- Marketing end
- 0000-00-00
- Substance
- VALPROATE SODIUM
- Active strength
- 100 mg/mL
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70860-784 | VALPROATE SODIUM INJECTION, SOLUTION [ATHENEX PHARMACEUTICAL DIVISION, LLC.] | 3 | Legacy NDC | 20250130_856ecdad-a8e0-4bda-a217-cd7948ddfa59.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-784-05 | 70860078405 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70860-784-05) > 5 mL in 1 VIAL, SINGLE-DOSE (70860-784-41) | 2022-11-01 | 0000-00-00 | No | No | Current |